Efficacy and safety of triple combination therapy with transarterial chemoembolization (TACE), tyrosine kinase inhibitor (TKI), and immune checkpoint inhibitor (ICI) versus dual combination therapy in unresectable hepatocellular carcinoma (uHCC): A systematic review and meta-analysis

被引：0
|
作者：
Maano, O. P. [1 ]
Malbas, J. M. V. [1 ]
Dy, C. [1 ]
机构：
[1] St Lukes Med Ctr Quezon City, Canc Inst, Quezon City, Philippines
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2147
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1003P
引用
收藏
页码：S614 / S614
页数：1
相关论文
共 50 条
  • [1] Role of Transarterial Chemoembolization in the Era of Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Combination Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score Matched Analysis
    Zhang, Jin-Xing
    Hua, Hong-jin
    Cheng, Yuan
    Liu, Sheng
    Shi, Hai-Bin
    Zu, Qing-Quan
    ACADEMIC RADIOLOGY, 2024, 31 (04) : 1304 - 1311
  • [2] Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis
    Li, Weiwei
    Pei, Yinxuan
    Wang, Zixiang
    Liu, Jinlong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [3] Immune checkpoint inhibitor plus tyrosine kinase inhibitor with or without transarterial chemoembolization for unresectable hepatocellular carcinoma
    Pan, Hongyu
    Ruan, Minghao
    Jin, Riming
    Zhang, Jin
    Li, Yao
    Wu, Dong
    Sun, Wen
    Wang, Ruoyu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] The efficacy and safety of solid tumors combination therapy with immune checkpoint inhibitor: A systematic review and meta-analysis
    Peng, M.
    Weng, Y.
    Yao, Y.
    Song, Q.
    ANNALS OF ONCOLOGY, 2018, 29
  • [5] The efficacy and safety of immune checkpoint inhibitor combination therapy in lung cancer: a systematic review and meta-analysis
    Peng, Min
    Li, Xing
    Lei, Gu
    Weng, Yi Ming
    Hu, Meng Xue
    Song, Qi Bin
    ONCOTARGETS AND THERAPY, 2018, 11 : 7369 - 7383
  • [6] The Efficacy and Safety of Solid Tumors Combination Therapy with Immune Checkpoint Inhibitor: A Systematic Review and Meta-Analysis
    Peng, M.
    Weng, Y.
    Yao, Y.
    Song, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S928 - S929
  • [7] Salvage immune checkpoint inhibitor (ICI) plus tyrosine kinase inhibitor (TKI) combination therapy for metastatic renal cell carcinoma (mRCC).
    Parikh, Anish B.
    Psutka, Sarah P.
    Yang, Yuanquan
    Collier, Katharine
    Miah, Abdul
    Li, Mingjia
    Mori-Vogt, Sherry
    Hinkley, Megan
    Orcutt, Delaney
    Trott, Elliott
    Gross, Evan
    Hussey, Duncan
    Kramer, Joel
    Oliva, Kaylee
    Mortazavi, Amir
    Monk, Paul
    Folefac, Edmund
    Clinton, Steven K.
    Yin, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [8] Systemic Chemotherapy with Combination of Immune Checkpoint Inhibitor and Tyrosine Kinase Inhibitor in Unresectable Hepatocellular Carcinoma
    Chon, Hye Yeon
    KOREAN JOURNAL OF GASTROENTEROLOGY, 2024, 83 (02): : 78 - 80
  • [9] Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis
    Wang, Wei
    Shi, Jian
    Xie, Wei-Fen
    LIVER INTERNATIONAL, 2010, 30 (05) : 741 - 749
  • [10] Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis
    Li, Lei
    Tian, Jiangke
    Liu, Peng
    Wang, Xuan
    Zhu, Zhenyu
    TUMORI JOURNAL, 2016, 102 (03): : 301 - 310
12345